BNP PARIBAS FINANCIAL MARKETS - EYEPOINT PHARMACEUTICALS INC ownership

EYEPOINT PHARMACEUTICALS INC's ticker is EYPT and the CUSIP is 30233G100. A total of 54 filers reported holding EYEPOINT PHARMACEUTICALS INC in Q3 2020. The put-call ratio across all filers is - and the average weighting 0.2%.

Quarter-by-quarter ownership
BNP PARIBAS FINANCIAL MARKETS ownership history of EYEPOINT PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2020$4,874,000
-77.9%
9,408
-67.6%
0.00%
Q2 2020$22,013,000
+11.3%
29,079
+50.0%
0.00%
Q1 2020$19,780,000
+76.1%
19,392
+167.5%
0.00%
Q4 2019$11,234,000
+102.6%
7,248
+136.6%
0.00%
Q3 2019$5,544,0003,0630.00%
Other shareholders
EYEPOINT PHARMACEUTICALS INC shareholders Q3 2020
NameSharesValueWeighting ↓
Essex Woodlands Management, Inc. 41,909,219$21,793,00011.58%
Kore Private Wealth LLC 202,366$105,0000.02%
BARD ASSOCIATES INC 335,750$175,0000.02%
HighTower Advisors, LLC 5,284,688$2,738,0000.01%
GSA CAPITAL PARTNERS LLP 126,529$66,0000.01%
BRIDGEWAY CAPITAL MANAGEMENT, LLC 654,200$339,0000.01%
Virtu Financial LLC 57,076$30,0000.01%
MATRIX ASSET ADVISORS INC/NY 39,500$20,0000.00%
NEXPOINT ASSET MANAGEMENT, L.P. 33,933$18,0000.00%
WEDBUSH SECURITIES INC 81,500$42,0000.00%
View complete list of EYEPOINT PHARMACEUTICALS INC shareholders